News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
539,527 Results
Type
Article (45572)
Company Profile (120)
Press Release (493835)
Multimedia
Podcasts (89)
Webinars (12)
Section
Business (147505)
Career Advice (2426)
Deals (28360)
Drug Delivery (123)
Drug Development (68643)
Employer Resources (154)
FDA (15758)
Job Trends (12189)
News (267730)
Policy (30105)
Tag
Academia (2327)
Academic (1)
Accelerated approval (6)
Adcomms (29)
Allergies (83)
Alliances (36789)
ALS (92)
Alzheimer's disease (1445)
Antibody-drug conjugate (ADC) (141)
Approvals (15704)
Artificial intelligence (254)
Autoimmune disease (27)
Automation (12)
Bankruptcy (313)
Best Places to Work (9378)
BIOSECURE Act (22)
Biosimilars (115)
Biotechnology (71)
Bladder cancer (80)
Brain cancer (27)
Breast cancer (272)
Cancer (2177)
Cardiovascular disease (193)
Career advice (2027)
Career pathing (33)
CAR-T (145)
Cell therapy (420)
Cervical cancer (20)
Clinical research (55932)
Collaboration (741)
Company closure (2)
Compensation (559)
Complete response letters (30)
COVID-19 (2614)
CRISPR (45)
C-suite (232)
Cystic fibrosis (96)
Data (2115)
Decentralized trials (2)
Denatured (15)
Depression (54)
Diabetes (276)
Diagnostics (5310)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (42)
Drug discovery (103)
Drug pricing (127)
Drug shortages (32)
Duchenne muscular dystrophy (100)
Earnings (59998)
Editorial (47)
Employer branding (20)
Employer resources (138)
Events (78816)
Executive appointments (671)
FDA (17096)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (652)
Gene editing (108)
Generative AI (22)
Gene therapy (326)
GLP-1 (809)
Government (4032)
Grass and pollen (6)
Guidances (145)
Healthcare (15145)
Huntington's disease (25)
IgA nephropathy (29)
Immunology and inflammation (145)
Indications (27)
Infectious disease (2763)
Inflammatory bowel disease (137)
Inflation Reduction Act (9)
Influenza (51)
Intellectual property (90)
Interviews (453)
IPO (14171)
IRA (48)
Job creations (3185)
Job search strategy (1682)
Kidney cancer (11)
Labor market (37)
Layoffs (524)
Leadership (23)
Legal (7048)
Liver cancer (74)
Lung cancer (308)
Lymphoma (147)
Machine learning (9)
Management (53)
Manufacturing (312)
MASH (77)
Medical device (11323)
Medtech (11326)
Mergers & acquisitions (14713)
Metabolic disorders (756)
Multiple sclerosis (77)
NASH (22)
Neurodegenerative disease (102)
Neuropsychiatric disorders (33)
Neuroscience (1993)
NextGen: Class of 2025 (5143)
Non-profit (3279)
Now hiring (26)
Obesity (416)
Opinion (219)
Ovarian cancer (73)
Pain (94)
Pancreatic cancer (82)
Parkinson's disease (150)
Partnered (16)
Patents (237)
Patient recruitment (104)
Peanut (44)
People (43358)
Pharmaceutical (35)
Pharmacy benefit managers (22)
Phase I (16738)
Phase II (24247)
Phase III (19848)
Pipeline (1329)
Policy (177)
Postmarket research (2222)
Preclinical (6798)
Press Release (28)
Prostate cancer (107)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (403)
Real estate (4365)
Recruiting (61)
Regulatory (21248)
Reports (32)
Research institute (2076)
Resumes & cover letters (405)
Rett syndrome (4)
RNA editing (3)
RSV (47)
Schizophrenia (78)
Series A (123)
Series B (81)
Service/supplier (9)
Sickle cell disease (55)
Special edition (18)
Spinal muscular atrophy (128)
Sponsored (33)
Startups (2785)
State (2)
Stomach cancer (16)
Supply chain (72)
Tariffs (54)
The Weekly (72)
Vaccines (779)
Venture capitalists (44)
Weight loss (299)
Women's health (32)
Worklife (20)
Date
Today (25)
Last 7 days (878)
Last 30 days (2826)
Last 365 days (29554)
2025 (10968)
2024 (31578)
2023 (35166)
2022 (45342)
2021 (48845)
2020 (46037)
2019 (37096)
2018 (28117)
2017 (28151)
2016 (26197)
2015 (28551)
2014 (22321)
2013 (18210)
2012 (19460)
2011 (19874)
2010 (17878)
Location
Africa (686)
Alabama (43)
Alaska (6)
Arizona (169)
Arkansas (10)
Asia (31588)
Australia (5525)
California (5804)
Canada (1581)
China (423)
Colorado (242)
Connecticut (273)
Delaware (142)
Europe (77463)
Florida (880)
Georgia (189)
Hawaii (1)
Idaho (36)
Illinois (450)
India (24)
Indiana (255)
Iowa (11)
Japan (152)
Kansas (85)
Kentucky (14)
Louisiana (7)
Maine (61)
Maryland (865)
Massachusetts (4355)
Michigan (183)
Minnesota (335)
Mississippi (1)
Missouri (70)
Montana (12)
Nebraska (19)
Nevada (59)
New Hampshire (51)
New Jersey (1632)
New Mexico (14)
New York (1597)
North Carolina (913)
North Dakota (6)
Northern California (2595)
Ohio (166)
Oklahoma (8)
Oregon (28)
Pennsylvania (1250)
Puerto Rico (10)
Rhode Island (22)
South America (1050)
South Carolina (23)
South Dakota (1)
Southern California (2192)
Tennessee (91)
Texas (839)
United States (21460)
Utah (154)
Virginia (136)
Washington D.C. (62)
Washington State (515)
West Virginia (3)
Wisconsin (57)
539,527 Results for "gn store nord a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annual General Meeting 2025 – GN Store Nord A/S
March 13, 2025
·
3 min read
Press Releases
National Organization for Rare Disorders (NORD®) Issues New Report on Life-Saving Newborn Screening Programs
February 11, 2025
·
3 min read
Press Releases
Tracey Sikora Joins the National Organization for Rare Disorders (NORD®) as Vice President of Research & Clinical Programs
December 12, 2024
·
3 min read
Press Releases
National Organization for Rare Disorders (NORD) Launches the Living Rare Study - First to Measure Full Scope of Rare Disease Challenges
October 22, 2024
·
3 min read
Press Releases
Kane to Host Investor Webinar – What Kane has in Store for 2025 Including the Acquisition of FB Dermatology
January 22, 2025
·
4 min read
Press Releases
National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome
October 1, 2024
·
2 min read
Biotech Bay
Scilex Holding Company Announces Major Initiative with a Leading National Pharmacy Chain to Stock GLOPERBA® in Most of Their Stores Throughout the U.S.
Scilex Holding Company announced a major initiative with a leading national pharmacy chain to stock GLOPERBA® in most of their stores throughout the U.S. GLOPERBA®, an FDA-approved prophylactic treatment for painful gout flares in adults in the U.S., is expected to launch in the U.S. in first half of 2024.
February 28, 2024
·
7 min read
Sonoma Pharmaceuticals Announces MicrocynAH for Animal Health Now Available Through Menards Home Improvement Stores
Sonoma Pharmaceuticals, Inc. today announced the launch of its MicrocynAH animal health care products in the Menards chain of home improvement stores in the United States.
May 9, 2024
·
4 min read
Biotech Beach
Genome Insight Announces Upcoming Presentations at 2023 NORD Breakthrough Summit on Enhancing Diagnostic Precision for Sensorineural Hearing Loss
Genome Insight is set to unveil clinical research findings on the genetic foundation of rare diseases at the 2023 NORD Rare Disease & Orphan Products Breakthrough Summit (2023 NORD Breakthrough Summit) in Washington, DC.
October 16, 2023
·
2 min read
Drug Development
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
September 25, 2024
·
2 min read
1 of 53,953
Next
